RecruitingPhase 4NCT07349810

Post Operative Infusion Pump Pain Study

Continuous Infusion Pump Versus Single Shot Peripheral Block for Pain Management After Same-day Orthopaedic Surgery


Sponsor

Rutgers, The State University of New Jersey

Enrollment

80 participants

Start Date

Jan 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study will be a pragmatic, prospective cluster randomized trial, where clusters will formed based on sequential 2 week time increments across the study recruitment period.. Patients 18 years or older undergoing ACL reconstruction, open shoulder labrum or rotator cuff surgery, arthroscopic rotator cuff repair, proximal or distal patellar realignment surgery, open knee arthrotomy cases (i.e. inside out meniscus repair, osteochondral allograft transplantation (OCA), meniscal allograft transplantation (MAT)) at University Center for Ambulatory Surgery, LLC (UOA) will be reviewed for eligibility. Once identified, potential study subjects will be asked whether they are interested in participating in the project. If the patient agrees, the subject will be given the informed consent to read and sign. Objectives: The primary objective is to compare the effectiveness of postoperative infusion pain pump versus preoperative nerve block in reducing visual analog pain scores/numerical pain rating scale (VAS/NPRS) in the postoperative period. The second objective is to evaluate the requirement of narcotic and non-narcotic analgesic medications between the two groups. Hypotheses: Use of continuous infusion pain pump or single shot peripheral block will result in similar post-operative pain control after outpatient sports medicine surgical cases.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Age 18 years or older
  • ACL reconstruction
  • Open shoulder labrum or rotator cuff surgery
  • Arthroscopic rotator cuff repair
  • Proximal or distal patellar realignment surgery
  • Open knee arthrotomy cases - Inside out meniscus repair, OCA, MAT

Exclusion Criteria10

  • Age under 18 years
  • Body mass index of greater than 40 kg/m2
  • American Society of Anesthesiologist class 4 physical status or greater
  • History of drug or alcohol abuse
  • Chronic opioid use/pain management doctor
  • Allergy to bupivacaine, ropivacaine or pharmacologic analogs
  • Any coagulation disorders
  • Existing nerve injury
  • Severe bronchopulmonary disease
  • Pregnant patients

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBupivacaine 0.5% Injectable Solution

Preoperatively, a nerve block consisting of 0.5% bupivacaine will be given to ALL patients * A bolus of 20cc will be used for saphenous nerve blocks for knee surgeries * A bolus of 15cc will be used for interscalene nerve blocks for shoulder surgeries

DRUGRopivacaine 0.2% Injectable Solution

Post-operative continuous infusion

DRUG1.3% liposomal bupivacaine (Exparel)

Pre-operative infiltrative of 10cc of 1.3% liposomal bupivacaine (Exparel)

DEVICEambIT Infusion Pump

A pain pump provides intermittent delivery of medication to manage post-surgery pain.


Locations(1)

University Center for Ambulatory Surgery

Somerset, New Jersey, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07349810


Related Trials